Hemophilia
A study investigated clinical outcomes before and after pharmacokinetic (PK)-guided dosing for hemophilia.
Genicular artery embolization showed promising results in reducing synovial hyperemia in patients with hemophilia.
Poor bleeding rates seen despite flawed data across studies on congenital hemophilia A without inhibitors on FVIII treatment.
Simoctocog alfa was effective as prophylaxis or treatment for bleeding in treatment-naïve patients with severe hemophilia A.
Fitusiran significantly reduced the annualized bleeding rate in patients with severe hemophilia, even those with inhibitors.
The group delineates the acute management of hemophilia patients, particularly with factor replacement.
The team starts their hemophilia series by discussing the nuances of evaluating a patient with a suspected bleeding disorder.
The group distinguishes between the two types of hemophilia: genetic and acquired.
Advertisement
Expert Interviews on Hematology
Advertisement
